The firm earned "Buy" rating on Friday, July 29 by UBS. (NASDAQ:GOOG), 26 have Buy rating, 0 Sell and 4 Hold. With short interest at 3,766,508 and short average daily volume at 1,345,474, days to cover is 3.0 and the percentage of shorted shares was 0.01% on September 15.
GOOGL has been the subject of a number of other reports. Nomura maintained Alphabet Inc (NASDAQ:GOOG) on Friday, October 23 with "Buy" rating. Baird reaffirmed an outperform rating and set a $960.00 price objective on shares of Alphabet in a report on Sunday, March 5th. The stock of Alphabet Inc (NASDAQ:GOOGL) has "Buy" rating given on Thursday, July 20 by Stifel Nicolaus. Finally, Morgan Stanley restated a "buy" rating on shares of Alphabet in a report on Friday, September 29th. Cullinan Associate Inc stated it has 0.27% of its portfolio in Alphabet Inc (NASDAQ:GOOG). The stock increased 1.24% or $2.54 during the last trading session, reaching $206.69. The firm has a 50 day moving average price of $940.16 and a 200 day moving average price of $923.18.
Beta is also an important valuation ratio for analyzing the stock of the company, GOOGL's beta remains at 0.91. Google has $1350.0 highest and $670 lowest target. Analysts forecast earnings per share of $8.43, up exactly $1.18 or 16.28 % from 2014's $7.25 EPS. Adams Diversified Equity Fund Incorporated has invested 1.52% in Alphabet Inc (NASDAQ:GOOG). The business had revenue of $20.92 billion during the quarter, compared to analyst estimates of $20.83 billion. During the same period in the previous year, the business earned $8.42 EPS.
YouTube advertising was hit past year when companies pulled their ads from the video site after some appeared next to inappropriate or offensive images. Equities analysts predict that Alphabet Inc. will post $30.59 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another site, it was illegally stolen and republished in violation of United States and worldwide copyright & trademark laws.
Alexion Pharmaceuticals, Inc.is a biopharmaceutical company. Asset Mgmt Group Inc accumulated 246 shares or 0.09% of the stock. The rating was downgraded by Canaccord Genuity to "Hold" on Thursday, June 15. Eastern Bank's holdings in Alphabet were worth $19,491,000 as of its most recent filing with the Securities and Exchange Commission. Also, CEO Sundar Pichai sold 4,000 shares of Alphabet stock in a transaction on Wednesday, October 4th. Neville Rodie & Shaw Inc. now owns 14,407 shares of the information services provider's stock valued at $14,028,000 after acquiring an additional 200 shares in the last quarter. Doyle Wealth Management grew its position in shares of Alphabet by 6.7% in the 2nd quarter. Quantres Asset Management Ltd trimmed its investment by selling 100 shares a decrease of 10.0% from 06/30/2017 to 09/30/2017. Jackson Grant Investment Advisers Inc. now owns 170 shares of the information services provider's stock worth $135,000 after buying an additional 1 shares in the last quarter. Farmers National Bank raised its stake in shares of Alphabet by 2.7% during the first quarter. Rothschild Investment Corp IL now owns 10,809 shares of the information services provider's stock valued at $9,823,000 after acquiring an additional 184 shares during the period. Finally, Shufro Rose & Co. InterOcean Capital LLC now owns 971 shares of the information services provider's stock worth $769,000 after buying an additional 3 shares during the period. Institutional investors and hedge funds own 33.85% of the company's stock. Pure Financial Advisors Inc. boosted its holdings in shares of Alphabet by 0.4% in the 2nd quarter. The Company's businesses include Google Inc. and its Internet products, such as Access, Calico, CapitalG, GV, Nest, Verily, Waymo and X. The company has market cap of $690.77 billion. The Other Bets segment is involved in the sales of Internet and television services through Google Fiber, sales of Nest products and services, and licensing and research and development (R&D) services through Verily.